Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Berry

Showing results (1241-1250 of 1,380) with videos related to

Pageof 138
Sort By:
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|October 20, 2015
Returning a Research Participant's Genomic Results to Relatives: Analysis and RecommendationsSusan M Wolf, Rebecca Branum, Barbara A Koenig, et al.
Scientific Reports|July 14, 2021
Malian adults maintain serologic responses to virulent PfEMP1s amid seasonal patterns of fluctuationNoah T Ventimiglia, Emily M Stucke, Drissa Coulibaly, et al.
Scientific Reports|February 21, 2017
Plasma Exosome Profiling of Cancer Patients by a Next Generation Systems Biology ApproachValeriy Domenyuk, Zhenyu Zhong, Adam Stark, et al.
Cancer Treatment Reviews|February 1, 2008
Dose-escalation of filgrastim does not improve efficacy: clinical tolerability and long-term follow-up on CALGB study 9141 adjuvant chemotherapy for node-positive breast cancer patients using dose-intensified doxorubicin plus cyclophosphamide followed by paclitaxelMinetta C Liu, George D Demetri, Donald A Berry, et al.
AIDS (London, England)|March 12, 2021
Racial, ethnic, and gender disparities in hospitalizations among persons with HIV in the United States and Canada, 2005-2015Thibaut Davy-Mendez, Sonia Napravnik, Joseph J Eron, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 6, 2014
Impact of the addition of carboplatin and/or bevacizumab to neoadjuvant once-per-week paclitaxel followed by dose-dense doxorubicin and cyclophosphamide on pathologic complete response rates in stage II to III triple-negative breast cancer: CALGB 40603 (Alliance)William M Sikov, Donald A Berry, Charles M Perou, et al.
Breast Cancer Research and Treatment|September 11, 2012
Lobular histology and response to neoadjuvant chemotherapy in invasive breast cancerEsther H Lips, Rita A Mukhtar, Christina Yau, et al.
Plos One|September 6, 2024
Assessment of sociodemographic factors associated with time to self-reported COVID-19 infection among a large multi-center prospective cohort population in the southeastern United StatesAndrew J Beron, Joshua O Yukich, Andrea A Berry, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|September 8, 2016
A Model for the Departmental Quality Management Infrastructure Within an Academic Health SystemSimon C Mathews, Renee Demski, Jody E Hooper, et al.
The Journal of Infectious Diseases|February 8, 2024
Recombinant Full-length Plasmodium falciparum Circumsporozoite Protein-Based Vaccine Adjuvanted With Glucopyranosyl Lipid A-Liposome Quillaja saponaria 21: Results of Phase 1 Testing With Malaria ChallengeDeAnna J Friedman-Klabanoff, Andrea A Berry, Mark A Travassos, et al.
Pageof 138

Showing results (1241-1250 of 1,380) with videos related to

Sort By:
Pageof 138
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|October 20, 2015
Returning a Research Participant's Genomic Results to Relatives: Analysis and RecommendationsSusan M Wolf, Rebecca Branum, Barbara A Koenig, et al.
Scientific Reports|July 14, 2021
Malian adults maintain serologic responses to virulent PfEMP1s amid seasonal patterns of fluctuationNoah T Ventimiglia, Emily M Stucke, Drissa Coulibaly, et al.
Scientific Reports|February 21, 2017
Plasma Exosome Profiling of Cancer Patients by a Next Generation Systems Biology ApproachValeriy Domenyuk, Zhenyu Zhong, Adam Stark, et al.
Cancer Treatment Reviews|February 1, 2008
Dose-escalation of filgrastim does not improve efficacy: clinical tolerability and long-term follow-up on CALGB study 9141 adjuvant chemotherapy for node-positive breast cancer patients using dose-intensified doxorubicin plus cyclophosphamide followed by paclitaxelMinetta C Liu, George D Demetri, Donald A Berry, et al.
AIDS (London, England)|March 12, 2021
Racial, ethnic, and gender disparities in hospitalizations among persons with HIV in the United States and Canada, 2005-2015Thibaut Davy-Mendez, Sonia Napravnik, Joseph J Eron, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 6, 2014
Impact of the addition of carboplatin and/or bevacizumab to neoadjuvant once-per-week paclitaxel followed by dose-dense doxorubicin and cyclophosphamide on pathologic complete response rates in stage II to III triple-negative breast cancer: CALGB 40603 (Alliance)William M Sikov, Donald A Berry, Charles M Perou, et al.
Breast Cancer Research and Treatment|September 11, 2012
Lobular histology and response to neoadjuvant chemotherapy in invasive breast cancerEsther H Lips, Rita A Mukhtar, Christina Yau, et al.
Plos One|September 6, 2024
Assessment of sociodemographic factors associated with time to self-reported COVID-19 infection among a large multi-center prospective cohort population in the southeastern United StatesAndrew J Beron, Joshua O Yukich, Andrea A Berry, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|September 8, 2016
A Model for the Departmental Quality Management Infrastructure Within an Academic Health SystemSimon C Mathews, Renee Demski, Jody E Hooper, et al.
The Journal of Infectious Diseases|February 8, 2024
Recombinant Full-length Plasmodium falciparum Circumsporozoite Protein-Based Vaccine Adjuvanted With Glucopyranosyl Lipid A-Liposome Quillaja saponaria 21: Results of Phase 1 Testing With Malaria ChallengeDeAnna J Friedman-Klabanoff, Andrea A Berry, Mark A Travassos, et al.
Pageof 138